NDC codes

FDA NDC Directory
Product NDC (as listed)71205-818Labeler and product segments. Claims need a package NDC.
Product NDC at billing width71205-0818Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
71205-818-05712050818055 TABLET in 1 BOTTLE, PLASTIC (71205-818-05)Marketed from Jul 3, 2023
71205-818-06712050818066 TABLET in 1 BOTTLE, PLASTIC (71205-818-06)Marketed from Jul 3, 2023
71205-818-07712050818077 TABLET in 1 BOTTLE, PLASTIC (71205-818-07)Marketed from Jul 3, 2023
71205-818-107120508181010 TABLET in 1 BOTTLE, PLASTIC (71205-818-10)Marketed from Jul 3, 2023
71205-818-127120508181212 TABLET in 1 BOTTLE, PLASTIC (71205-818-12)Marketed from Jul 3, 2023
71205-818-147120508181414 TABLET in 1 BOTTLE, PLASTIC (71205-818-14)Marketed from Jul 3, 2023
71205-818-157120508181515 TABLET in 1 BOTTLE, PLASTIC (71205-818-15)Marketed from Jul 3, 2023
71205-818-207120508182020 TABLET in 1 BOTTLE, PLASTIC (71205-818-20)Marketed from Jul 3, 2023
71205-818-217120508182121 TABLET in 1 BOTTLE, PLASTIC (71205-818-21)Marketed from Jul 3, 2023
71205-818-247120508182424 TABLET in 1 BOTTLE, PLASTIC (71205-818-24)Marketed from Jul 3, 2023
71205-818-287120508182828 TABLET in 1 BOTTLE, PLASTIC (71205-818-28)Marketed from Jul 3, 2023
71205-818-307120508183030 TABLET in 1 BOTTLE, PLASTIC (71205-818-30)Marketed from Jul 3, 2023
71205-818-407120508184040 TABLET in 1 BOTTLE, PLASTIC (71205-818-40)Marketed from Jul 3, 2023
71205-818-427120508184242 TABLET in 1 BOTTLE, PLASTIC (71205-818-42)Marketed from Jul 3, 2023
71205-818-607120508186060 TABLET in 1 BOTTLE, PLASTIC (71205-818-60)Marketed from Jul 3, 2023
71205-818-907120508189090 TABLET in 1 BOTTLE, PLASTIC (71205-818-90)Marketed from Jul 3, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
prednisone
Generic name (nonproprietary)
prednisone
Active ingredients
Prednisone — 10 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 213386
Marketing start
Listing expires
Other FDA classes
Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers
Product ID 71205-818_6ec5b58c-65e9-47ee-b2ac-7d0b395a0630SPL ID 6ec5b58c-65e9-47ee-b2ac-7d0b395a0630SPL set ID 6ec5b58c-65e9-47ee-b2ac-7d0b395a0630RxCUI 198145UNII VB0R961HZTUPC 0371205818210
Pharmacologic class
Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205081805 followed by a unit qualifier and the quantity

Package 71205-0818-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS Prednisone tablets are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) Congenital adrenal hyperplasia Hypercalcemia associated with cancer Nonsuppurative thyroiditis 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may requir…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213386

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213386
ProductStrengthForm · routeLabelerProduct NDC
prednisonePrednisone 20 mg/1TabletOralRedpharm Drug67296-2081
prednisonePrednisone 10 mg/1TabletOralA-S Medication Solutions50090-7369
prednisonePrednisone 10 mg/1TabletOralA-S Medication Solutions50090-7371
prednisonePrednisone 10 mg/1TabletOralNCS HealthCare of KY, LLC dba Vangard Labs0615-8440
prednisonePrednisone 20 mg/1TabletOralNCS HealthCare of KY, LLC dba Vangard Labs0615-8441
prednisonePrednisone 10 mg/1TabletOralUnit Dose Solutions, Inc.87441-069
prednisonePrednisone 20 mg/1TabletOralA-S Medication Solutions50090-6123
prednisonePrednisone 10 mg/1TabletOralAmneal Pharmaceuticals NY LLC60219-1707
prednisonePrednisone 20 mg/1TabletOralA-S Medication Solutions50090-6122
prednisonePrednisone 20 mg/1TabletOralAmneal Pharmaceuticals NY LLC60219-1708
prednisonePrednisone 10 mg/1TabletOralREMEDYREPACK INC.70518-4354
prednisonePrednisone 20 mg/1TabletOralREMEDYREPACK INC.70518-3540
prednisonePrednisone 20 mg/1TabletOralProficient Rx LP71205-797
prednisonePrednisone 20 mg/1TabletOralA-S Medication Solutions50090-6259

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in